Evidence map›Paper›PMID 20201848›Full record

ReviewAnnals of the New York Academy of Sciences2010

Amphetamine toxicities: classical and emerging mechanisms.

Bryan K Yamamoto, Anna Moszczynska, Gary A Gudelsky

Abstract readReview
In one paragraph

Review in Annals of the New York Academy of Sciences, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 134 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

134 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Observational
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bryan K YamamotoDepartment of Neurosciences, University of Toledo College of Medicine, Toledo, Ohio 43614, USA. bryan.yamamoto@utoledo.edu
Anna Moszczynska
Gary A Gudelsky

Funding

METHAMPHETAMINE TOXICITY AND CORTICOSTRIATAL GLUTAMATER01DA007606 · NIDA · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI YAMAMOTO, BRYAN K · 1992 to 2016
$5.1M
MICRODIALYSIS STUDIES ON MDMA-INDUCED NEUROTOXICITYR01DA007427 · NIDA · UNIVERSITY OF CINCINNATI · PI GUDELSKY, GARY · 1992 to 2010
$2.8M
Chronic Stress and MDMA NeurotoxicityR01DA016866 · NIDA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI YAMAMOTO, BRYAN K · 2003 to 2006
$1.3M
Role of Tyrosine in MDMA ToxicityR01DA019486 · NIDA · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI YAMAMOTO, BRYAN K · 2006 to 2010
$1.3M
The Role of Ubiquitination in Methamphetamine Neurotoxicity (CDA)R00DA023085 · NIDA · WAYNE STATE UNIVERSITY · PI MOSZCZYNSKA, ANNA · 2010 to 2012
$732k
The Role of Ubiquitination in Methamphetamine Neurotoxicity (CDA)K99DA023085 · NIDA · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI MOSZCZYNSKA, ANNA · 2008 to 2009
$179k
NIDA NIH HHS DA07427NIDA NIH HHS DA07606NIDA NIH HHS DA16866NIDA NIH HHS DA19486NIDA NIH HHS DA23085NIDA NIH HHS K99 DA023085NIDA NIH HHS R00 DA023085NIDA NIH HHS R01 DA007427NIDA NIH HHS R01 DA007606NIDA NIH HHS R01 DA016866NIDA NIH HHS R01 DA019486
6 · The paper itself

Abstract

The drugs of abuse, methamphetamine and MDMA, produce long-term decreases in markers of biogenic amine neurotransmission. These decreases have been traditionally linked to nerve terminals and are evident in a variety of species, including rodents, nonhuman primates, and humans. Recent studies indicate that the damage produced by these drugs may be more widespread than originally believed. Changes indicative of damage to cell bodies of biogenic and nonbiogenic amine-containing neurons in several brain areas and endothelial cells that make up the blood-brain barrier have been reported. The processes that mediate this damage involve not only oxidative stress but also include excitotoxic mechanisms, neuroinflammation, the ubiquitin proteasome system, as well as mitochondrial and neurotrophic factor dysfunction. These mechanisms also underlie the toxicity associated with chronic stress and human immunodeficiency virus (HIV) infection, both of which have been shown to augment the toxicity to methamphetamine. Overall, multiple mechanisms are involved and interact to promote neurotoxicity to methamphetamine and MDMA. Moreover, the high coincidence of substituted amphetamine abuse by humans with HIV and/or chronic stress exposure suggests a potential enhanced vulnerability of these individuals to the neurotoxic actions of the amphetamines.

Indexed as

AmphetaminesAnimalsBlood-Brain BarrierBrainCentral Nervous System StimulantsHIV InfectionsHumansIllicit DrugsMethamphetamineN-Methyl-3,4-methylenedioxyamphetamineOxidative StressStress, PhysiologicalSubstance-Related DisordersAmphetaminesCentral Nervous System StimulantsIllicit DrugsMethamphetamineN-Methyl-3,4-methylenedioxyamphetamine

Identifiers

PMID20201848
PMCPMC3955986

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.